Pharmaceutical glass manufacturer Schott has invested €20 million in its Jambusar, Gujarat, India plant

The German technology group said it was growing its production capacity with a new tank facility.

The expansion is in response to increased demand for pharmaceutical packaging material in the global market.

Construction work on the new tank facility has already begun and is expected to be completed in 18 months. Production from the new tank is scheduled to begin by January 2020.

The new facility will increase production capacity by an additional 50% and provide jobs for 70 additional local workers, bringing the total count to 425 staff.

Dr. Patrick Markschlaeger, Executive Vice President, Schott Business Unit Tubing, said: ‘‘The rapid development of the Indian pharmaceutical market requires a strong growth of high-end pharmaceutical packaging and in consequence high-end pharmaceutical tubing.

“We estimate a market growth for premium packaging and therefore for tubing to continue on a very strong level in the coming years.

"In addition to the supply of the domestic market, Schott Tubing India will also serve the strong growing Asian market outside of India and will therefore be an important hub for the Asian market.”

Schott will also build new construction for energy supply, workshops and warehouse. There will also be an expansion of storage the energy, engineering and logistics infrastructure within the plant.

The plant functions as a production hub for Scott’s pharmaceutical tubing in Asia and produces FIOLAX pharmaceutical tubing.

FIOLAX provides a quality standard in the industry through Schott’s perfeXion process.

PerfeXion stands for the transition from statistical quality control to 100% automated inspection of each individual FIOLAX tube – based on big data. Hence, Industry 4.0 has been introduced to its Indian factory.